CTRI/2019/04/018554Completed未知
To determine expression profiles of Atopic Dermatitis biomarkers - SLSID1737
Strand Life Sciences Pvt Ltd0 sites12 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 12
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •1.Confirmed diagnosis of Moderate to Severe Atopic Dermatitis
- •2.Any adult age group, above 18 years
- •3.ADSI of 6-15
- •4.Patients willing to provide Informed Consent
Exclusion Criteria
- •1.Samples from children under 18yrs of age
- •2.Patients unwilling to provide Informed Consent
- •3. Patients undergoing treatment for any other severe medical conditions
Investigators
Similar Trials
Terminated
Phase 4
A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS WithdrawalDermatitis, AtopicNCT02317276University of California, San Francisco11
Recruiting
Not Applicable
Investigating biomarkers for development of atopic dermatitis in early childhood using maternal-infant hair-related microRNAEczemaJPRN-UMIN000027834Departments of Pediatrics Juntendo University, Faculty of Medicine 3-1-3 Hongo, Bunkyo-ku TOKYO, 113-0033, JAPAN TEL +81-3-3813-3111 FAX +81-3-5800-1580500
Completed
Phase 4
Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin AnalysisAtopic DermatitisNCT05436535National Institute of Allergy and Infectious Diseases (NIAID)433
Not yet recruiting
Unknown
A study to classify atopic dermatitis based on serum immunoglobulin E and interleukin levelsCTRI/2023/11/059864Arun V P
Completed
Not Applicable
Observation of atopic dermatitis in high-performance shower heads with a general shower head as a control Double-blind randomized trialAtopic dermatitisJPRN-UMIN000041204Takashima Clinic57